Improving medication adherence for Black women with breast cancer using mobile health tools
Developing a culturally tailored mHealth symptom monitoring intervention to improve adherence to endocrine therapy among Black women with breast cancer
This study is all about helping Black women with breast cancer stick to their hormone therapy by using a mobile health program that fits their unique needs and preferences, making it easier for them to manage symptoms and get the support they deserve.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10930838 on NIH RePORTER |
What this research studies
This research focuses on creating a mobile health intervention specifically designed to help Black women with breast cancer adhere to their endocrine therapy. By tailoring the intervention to the cultural needs and preferences of this population, the project aims to enhance the effectiveness of treatment through better symptom monitoring and support. The approach includes training and mentorship in developing behavioral interventions, ensuring that the methods used are both scientifically sound and culturally relevant. Patients will be engaged in the process to ensure their needs are met and to improve overall health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black women diagnosed with breast cancer who are undergoing endocrine therapy.
Not a fit: Patients who are not Black or those who are not undergoing endocrine therapy for breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment adherence and better health outcomes for Black women with breast cancer.
How similar studies have performed: Previous research has shown success in using culturally tailored interventions to improve health outcomes in minority populations, suggesting a promising approach for this project.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Lee, Kimberley T — University of Pennsylvania
- Study coordinator: Lee, Kimberley T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.